240 results
Page 8 of 12
20-F/A
EX-4.38
1orvdwejdhu9ly9
23 Mar 15
Annual report (foreign) (amended)
12:00am
20-F/A
b56nnttf12geeamu10
23 Mar 15
Annual report (foreign) (amended)
12:00am
6-K
EX-99
53n08n43wj2dcb
23 Mar 15
BioLineRx Reports Year End 2014 Financial Results
12:00am
20-F/A
EX-4.39
3ozk2im6lwup0x4k8l
23 Mar 15
Annual report (foreign) (amended)
12:00am
424B5
3tlcf f36ob5
6 Mar 15
Prospectus supplement for primary offering
12:00am
6-K
EX-99
dnbws0
6 Mar 15
BioLineRx Prices $25 Million Underwritten Public Offering
12:00am
6-K
EX-99.3
lw6q0pircq7quk
5 Mar 15
Current report (foreign)
12:00am
424B5
6rkfsn2r
5 Mar 15
Prospectus supplement for primary offering
12:00am
6-K
EX-99.2
64ttb2 kv
5 Mar 15
Current report (foreign)
12:00am
6-K
EX-99
aay3og
2 Mar 15
Current report (foreign)
12:00am
6-K
EX-99.1
7yrpl4465rozcl97t
14 Jan 15
BioLineRx Announces Completion of Enrollment in CE
12:00am
6-K
EX-99
9q1mdzwabv0
6 Jan 15
BioLineRx Completes Dose Escalation Stage of
12:00am
6-K
EX-99
ej8875f zd7duy
23 Dec 14
Current report (foreign)
12:00am
6-K
EX-99
94ccx2r
16 Dec 14
Current report (foreign)
12:00am
6-K
EX-99
hsjxo
12 Dec 14
BioLineRx Presents Multi-Year Clinical Development
12:00am
6-K
EX-99
wh4d39me
8 Dec 14
BioLineRx Reports Positive Data from Ongoing Phase 2a
12:00am
6-K
EX-99
t1b0b25 ey
10 Nov 14
BioLineRx Reports Third Quarter 2014 Financial Results
12:00am